Xenetic Biosciences Inc.

1.00-0.0200-1.96%Vol 158.36K1Y Perf -92.04%
Jul 13th, 2020 16:00 DELAYED
BID0.9900 ASK1.04
Open1.04 Previous Close1.02
Pre-Market- After-Market-
 - -%  - -%
Target Price
2.25 
Analyst Rating
Strong Buy 1.00
Potential %
125.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★ —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap6.28M 
Earnings Rating
Neutral
Price Range Ratio 52W %
4.23 
Earnings Date
20th Aug 2020

Today's Price Range

0.97011.04

52W Range

0.440013.68

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-0.99%
1 Month
-3.85%
3 Months
22.00%
6 Months
-33.33%
1 Year
-92.04%
3 Years
-97.00%
5 Years
-98.80%
10 Years
-

TickerPriceChg.Chg.%
XBIO1.00-0.0200-1.96
AAPL381.91-1.7700-0.46
GOOG1 511.340.35000.02
MSFT207.07-6.6000-3.09
XOM42.660.01000.02
WFC25.41-0.0600-0.24
JNJ145.212.84001.99
FB239.00-6.0700-2.48
GE6.700.01000.15
JPM97.651.38001.43
Earnings HistoryEstimateReportedSurprise %
Q01 2020-0.37-0.1948.65
Q03 2017--0.26-
Q02 2017--0.34-
Q01 2017--0.34-
Q04 2016--0.28-
Q02 2016--5.55-
Q01 2016--0.66-
----
Earnings Per EndEstimateRevision %Trend
6/2020 QR-0.22--
9/2020 QR-0.23--
12/2020 FY-0.93--
12/2021 FY-0.38--
Next Report Date20th Aug 2020
Estimated EPS Next Report-0.22
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume158.36K
Shares Outstanding6.28M
Trades Count277
Dollar Volume160.18K
Avg. Volume379.73K
Avg. Weekly Volume169.36K
Avg. Monthly Volume392.97K
Avg. Quarterly Volume337.16K

Xenetic Biosciences Inc. (NASDAQ: XBIO) stock closed at 1 per share at the end of the most recent trading day (a -1.96% change compared to the prior day closing price) with a volume of 158.37K shares and market capitalization of 6.28M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 4 people. Xenetic Biosciences Inc. CEO is Jeffrey F. Eisenberg.

The one-year performance of Xenetic Biosciences Inc. stock is -92.04%, while year-to-date (YTD) performance is -30.56%. XBIO stock has a five-year performance of -98.8%. Its 52-week range is between 0.44 and 13.68, which gives XBIO stock a 52-week price range ratio of 4.23%

Xenetic Biosciences Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 0.62, a price-to-sale (PS) ratio of 85.14, a price to cashflow ratio of 10.40, a PEG ratio of 2.32, a ROA of -75.68%, a ROC of -101.27% and a ROE of -101.27%. The company’s profit margin is -%, its EBITDA margin is -12 834.30%, and its revenue ttm is $73.82 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from Xenetic Biosciences Inc., there were 1 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.22 for the next earnings report. Xenetic Biosciences Inc.’s next earnings report date is 20th Aug 2020.

The consensus rating of Wall Street analysts for Xenetic Biosciences Inc. is Strong Buy (1), with a target price of $2.25, which is +125.00% compared to the current price. The earnings rating for Xenetic Biosciences Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Xenetic Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Xenetic Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 35.46, ATR14 : 0.09, CCI20 : -60.27, Chaikin Money Flow : -0.24, MACD : 0.00, Money Flow Index : 47.96, ROC : 2.04, RSI : 47.78, STOCH (14,3) : 44.00, STOCH RSI : 0.11, UO : 42.46, Williams %R : -56.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Xenetic Biosciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.

CEO: Jeffrey F. Eisenberg

Teplephone: +1 781 778-7720

Address: 40 Speen Street, Framingham 01701, MA, USA

Number of employees: 4

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

44%56%

Bearish Bullish

59%41%

Bearish Bullish

69%31%

News

Stocktwits